Clinical Trial Update: Rifaximin Therapy vs Low FODMAP Diet In IBS [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing rifaximin therapy to a low FODMAP diet in irritable bowel syndrome and small intestinal bacterial overgrowth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Small Intestinal Bacterial Overgrowth

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: University of Malaya | Conditions: Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth | Phase 4 | Status: UNKNOWN